Effects of Subcutaneous and Intravenous Recombinant Human Erythropoietin Treatments on Body Iron in Rats

Recombinant human erythropoietin (rHuEPO) is used widely in clinical practice for correcting anemia related to renal failure, cancer chemotherapy, HIV infection, premature infants, and chronic diseases. Recombinant human erythropoietin is known to affect body iron status that may result in functiona...

Full description

Saved in:
Bibliographic Details
Main Author: Ahmed Shujaaedin, Hareth Yahya
Format: Thesis
Language:English
English
Published: 2009
Online Access:http://psasir.upm.edu.my/id/eprint/11540/1/FPV_2009_15.pdf
http://psasir.upm.edu.my/id/eprint/11540/
Tags: Add Tag
No Tags, Be the first to tag this record!